ASX:ACL Australian Clinical Labs (ACL) Stock Price, News & Analysis → The only accurate crypto trading system I know … (From Weiss Ratings) (Ad) Free ACL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.72%Price TargetN/A Stock AnalysisStock Analysis Get Australian Clinical Labs alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Australian Clinical Labs Stock (ASX:ACL)Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 2020 and is headquartered in Clayton, Australia.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… ACL Stock News HeadlinesApril 18, 2024 | morningstar.comAustralian Clinical Labs LtdApril 2, 2024 | au.news.yahoo.comTruth Social made 1000 times less money than X last yearApril 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 31, 2024 | sg.finance.yahoo.comIs It Too Late To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?March 27, 2024 | au.investing.comASX 200 adds 0.8% as S&P 500 resets record valuationsFebruary 18, 2024 | au.lifestyle.yahoo.comWith Twilio under activist pressure, Segment could be put up for saleFebruary 16, 2024 | finance.yahoo.comIs Australian Clinical Labs Limited's (ASX:ACL) Latest Stock Performance A Reflection Of Its Financial Health?January 20, 2024 | uk.finance.yahoo.comIs There An Opportunity With Australian Clinical Labs Limited's (ASX:ACL) 36% Undervaluation?April 25, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.January 11, 2024 | afr.comWhy this fundie is backing ACL, Ramsay and DexusDecember 14, 2023 | msn.comHealius shares tumble as Australian Clinical Labs intends to withdraw $1 billion offerDecember 14, 2023 | msn.comAustralian Clinical Labs to withdraw $1 billion offer for Healius; stocks fallDecember 14, 2023 | afr.comACL pulls Healius bid as ACCC blocks pathology shake-upDecember 14, 2023 | news.yahoo.comAustralian regulator kills ACL's $1 billion bid for rival HealiusDecember 14, 2023 | ca.finance.yahoo.comAustralian Clinical Labs to withdraw its $1 billion offer to buy HealiusDecember 14, 2023 | marketwatch.comAustralian Clinical Labs Withdraws Takeover Offer for HealiusDecember 14, 2023 | reuters.comAustralian Clinical Labs to withdraw its $1 bln offer to buy HealiusNovember 29, 2023 | theguardian.comMedical test company’s ‘serious and systemic failures’ led to cyber-attack, watchdog saysNovember 28, 2023 | afr.comSexual health and fertility details leaked in ACL data breachNovember 23, 2023 | afr.comACL accuses Wylie of hiding links to independent Healius directorNovember 20, 2023 | afr.comDividend drought adds to pain for Healius shareholdersNovember 20, 2023 | afr.comHealius preps $200 million equity raising; Barrenjoey on ticketNovember 5, 2023 | fool.com.auThis ASX healthcare share just hit a 52-week low, is it time to buy?November 3, 2023 | msn.comLive: ASX jumps after Wall Street bounce, as Qantas faces shareholders and ACL faces hacking proceedingsOctober 30, 2023 | afr.comCrescent Capital claims stake in clinical trials biz WalskiOctober 23, 2023 | finance.yahoo.comWhat Does Australian Clinical Labs Limited's (ASX:ACL) Share Price Indicate?August 12, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of Australian Clinical Labs Limited (ASX:ACL)See More Headlines Receive ACL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/25 Dividend3/27/2024Today4/25/2024Dividend Payable4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:ACL CUSIPN/A CIKN/A Webwww.clinicallabs.com.au Phone61 3 9538 6777FaxN/AEmployees5,115Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.08 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.36Net Income$15.43 million Net Margins2.29% Pretax MarginN/A Return on Equity9.19% Return on Assets5.58% Debt Debt-to-Equity Ratio198.17 Current Ratio0.66 Quick Ratio0.53 Sales & Book Value Annual Sales$674.03 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.82 per share Price / BookN/AMiscellaneous Outstanding Shares201,830,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.14 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMs. Melinda McGrathCEO & Executive DirectorMr. James DavisonChief Financial OfficerMr. Anthony FriedliChief Operating OfficerMr. Sean JacksonChief Information OfficerMr. Joe GeranNational Marketing DirectorAssociate Prof. Tony LandgrenNational Medical Director & Chief PathologistMr. Chris BrownlowChief Executive Officer of New South Wales & Australian Capital TerritoryMs. Shae SeymourChief Executive Officer of Western AustraliaMr. Eric SwaynChief Executive Officer of South Australia & Northern TerritoryMs. Eleanor Padman B.A.FCIS, Company SecretaryMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWBiomark DiagnosticsCNSX:BUXView All CompetitorsInsidersChristine BartlettBought 20,000 shares on 2/28/2024Total: $47,160.00 ($2.36/share) ACL Stock Analysis - Frequently Asked Questions How often does Australian Clinical Labs pay dividends? What is the dividend yield for Australian Clinical Labs? Australian Clinical Labs announced a Interim dividend on Wednesday, March 27th. Stockholders of record on Thursday, April 25th will be paid a dividend of 0.03 per share on Thursday, April 25th. This represents a dividend yield of 1.1%. The ex-dividend date of this dividend is Wednesday, March 27th. Read our dividend analysis for ACL. Is Australian Clinical Labs a good dividend stock? Australian Clinical Labs (ASX:ACL) pays an annual dividend of A$0.10 per share and currently has a dividend yield of 3.72%. The dividend payout ratio is 125.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for ACL. This page (ASX:ACL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Clinical Labs Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
